Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin and Lenvatinib in Advanced Solid Tumors
NCT02640508Phase 2Completed
- Start
- May 2016
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eribulin, lenvatinib in breast cancer, non-small cell lung cancer (NSCLC), sarcoma. Started May 2016; status: completed.
02
Drugs
eribulinlenvatinib
03
Conditions
breast cancernon-small cell lung cancer (NSCLC)sarcoma
Beyond the preview
Go deeper on NCT02640508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02640508.